CSPC Pharmaceutical Group (HKSE:01093) Change In Receivables : HK$0 Mil (TTM As of Jun. 2024)

View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group Change In Receivables?

CSPC Pharmaceutical Group's change in receivables for the quarter that ended in Jun. 2024 was HK$0 Mil. It means CSPC Pharmaceutical Group's Accounts Receivable stayed the same from Mar. 2024 to Jun. 2024 .

CSPC Pharmaceutical Group's change in receivables for the fiscal year that ended in Dec. 2023 was HK$-3,601 Mil. It means CSPC Pharmaceutical Group's Accounts Receivable increased by HK$3,601 Mil from Dec. 2022 to Dec. 2023 .

CSPC Pharmaceutical Group's Accounts Receivable for the quarter that ended in Jun. 2024 was HK$6,829 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CSPC Pharmaceutical Group's Days Sales Outstanding for the three months ended in Jun. 2024 was 79.27.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CSPC Pharmaceutical Group's liquidation value for the three months ended in Jun. 2024 was HK$6,201 Mil.

CSPC Pharmaceutical Group Change In Receivables Historical Data

The historical data trend for CSPC Pharmaceutical Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Change In Receivables Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-1,079.59

-53.96

-2,350.45

-504.44

-3,601.14

CSPC Pharmaceutical Group Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

CSPC Pharmaceutical Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.

CSPC Pharmaceutical Group (HKSE:01093) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CSPC Pharmaceutical Group's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	6828.705	/	7860.434	*	91
=	79.27

2. In Ben Graham's calculation of liquidation value, CSPC Pharmaceutical Group's accounts receivable are only considered to be worth 75% of book value:

CSPC Pharmaceutical Group's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	11617.6	-	12298.44	+	0.75 * 6828.705	+	0.5 * 3521.065
=	6,201

CSPC Pharmaceutical Group Change In Receivables Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CSPCY:USA CHJTF:USA CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

Executives

Ubs Group Ag	2201 Interest of corporation controlled by you
Cai Dong Chen	2201 Interest of corporation controlled by you
Citigroup Inc.	2502 Approved lending agent
Blackrock, Inc.	2201 Interest of corporation controlled by you
True Ally Holdings Limited	2201 Interest of corporation controlled by you
Gong Cheng Guo Ji You Xian Gong Si	2101 Beneficial owner
Ding Da Ji Tuan You Xian Gong Si	2101 Beneficial owner

CSPC Pharmaceutical Group Headlines

No Headlines